Skip to Main Content

Paper Details

Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells.
ACS Synth Biol
4
2022
Author NameAffiliation
Jeremy M SimonLineberger Comprehensive Cancer Center
  • 1 - 1

Datasets

Release 1.2